

Using fluorescent calcium sensors, Tohoku University researchers have now tracked astrocyte activity and found that it begins about 20 seconds prior to the commencement of epileptic neuronal hyperactivity. This implies that astrocytes have a major role in inducing epileptic seizures by promoting the neuronal circuit’s hyperdrive.
On April 9, 2024, these results were published in full in the journal Glia.
Nearly half of the brain is made up of non-neuronal glial cells called astrocytes. It has been demonstrated that they regulate the metabotropic and ionic conditions locally. However, due to their lack of readily observable electrical activity, their significance in brain function has been generally overlooked. This is being altered by fluorescent sensor proteins, which provide additional insight into the fascinating activity of astrocytes.
“Astrocytes appear to have a determinant role in controlling the state of neuronal activity and synaptic plasticity both in physiological and pathophysiological situations,” said the study’s principal investigator, Professor Ko Matsui of Tohoku University’s Super-network Brain Physiology lab. “Therefore, astrocytes could be considered as a new therapeutic target for epilepsy treatment.”
The astrocyte calcium increased significantly in response to this stimulation, the researchers observed, and this was followed by an epileptic neuronal hyperactivity episode. The amount of epileptic neuronal excitability was greatly decreased when fluorocitrate was applied to the astrocytes to limit their metabolic activity. All of these suggest that astrocytes may be able to regulate neural activity.
Shun Araki, the study’s lead scientist, emphasized that astrocytes’ abilities could be used to treat a variety of neurological disorders with the right direction. This covers epilepsy as well as the possibility of improving cognitive capacities over and above their inherent constraints.
For more information: Astrocyte switch to the hyperactive mode, Glia, DOI: 10.1002/glia.24537
more recommended stories
Shingles Vaccine May Cut Dementia Risk by 20%
A new study shows that the.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Leave a Comment